Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy2018-01-17T17:06:02-05:00
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis2018-01-17T17:04:46-05:00
